Clinical Trial Update: Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating partial-agonists to reduce ethanol and tobacco use in people with HIV; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• HIV Infection
• Smoking-related Disease

Snippet

Sponsor: Boston Medical Center | Conditions: HIV Infection, Alcohol Use | Phase 2, Phase 3 | Status: COMPLETED